18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.
<h4>Objective</h4>The aim of this study is to evaluate the diagnostic performance of FDG-PET/CT for the detection of residual disease after (chemo)radiotherapy in patients with head and neck squamous cell carcinoma (HNSCC) and to evaluate the prognostic value of the FDG-PET/CT findings.&...
Main Authors: | Nils Helsen, Dessie Roothans, Bert Van Den Heuvel, Tim Van den Wyngaert, Danielle Van den Weyngaert, Laurens Carp, Sigrid Stroobants |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182350&type=printable |
Similar Items
-
Quality Assessment in FDG-PET/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two Doubles
by: Tim Van den Wyngaert, et al.
Published: (2020-08-01) -
Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer.
by: Dandekar, P, et al.
Published: (2010) -
FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma
by: Brambilla Marco, et al.
Published: (2008-09-01) -
Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy
by: Frederik Soffers, et al.
Published: (2022-06-01) -
Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
by: Newbold, K, et al.
Published: (2008)